WKWilma De Grava Kempinas

Wilma De Grava Kempinas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wilma De Grava Kempinas has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Intergenerational disruptions to reproductive, physical, and neurobehavioral development in rats after prenatal exposure to the emergent pollutant betamethasone

    by Thamiris Moreira Figueiredo, Jorge Willian Franco de Barros, Lethícia Valencise, Mayara Silva Moura, Ana Flávia Quiarato Lozano, Josiane de Lima Rosa, Patrícia Villela e Silva, Wilma De Grava Kempinas

  • Open Access

    Postnatal development outcomes in mice after gestational exposure to polystyrene nanoplastics

    by Lethícia Valencise, Ana Flávia Quiarato Lozano, Jorge Willian Franco de Barros, Daniel G. Cyr, Wilma De Grava Kempinas

    Nanoplastics (< 1 μm) are contaminants of emerging concern. Humans are daily exposed to these particles, and they have even been found in placental tissue, raising concern regarding gestational exposure. Thus, the present work aimed to investigate the effects of gestational exposure to polystyrene nanoplastics (PS-NP) and postnatal development outcomes. Female C57BL/6 mice (n = 9) where mated with male BALB/c mice (n = 9). Dams were separated into two experimental groups: PS-NP (n = 4), which was treated by gavage with 0.15 mg/d (7.5 mg/kg/d) of PS-NP (500 nm) diluted in distilled water (vehicle), and Control (n = 5), which was treated by gavage with distilled water between gestational days 5 and 19. The offspring were evaluated for developmental milestones between postnatal days (PND) 1 and 21. Males were euthanized on PND 42 and 70 to assess organ weights, testes and epididymides development, and sperm quality. In the PS-NP group, females had increased anogenital distance (AGD), while males showed a tendency toward reduced AGD and delayed cliff-avoidance reflex. On PND 42, males had significantly lower brain and kidney weights. Considering the small sample size, these preliminary findings highlight that even low doses of PS-NP during pregnancy may affect early development, raising concerns regarding human health and fertility.

  • Direct and intergenerational effects in reproductive parameters of adult male Wistar rats and their offspring after subchronic exposure to polystyrene nanoplastics

    by Lethícia Valencise, Ana Flávia Quiarato Lozano, Jorge Willian Franco de Barros, Carina Funck Godoy, Cibele dos Santos Borges, Daniel G. Cyr, Wilma De Grava Kempinas


  • Exposure to low-dose polystyrene nanoplastics impairs the estrous cycle by decreasing ovarian levels of steroidogenic acute regulatory protein and serum progesterone levels in rats

    by Lethícia Valencise, Jorge Willian Franco de Barros, Ana Flávia Quiarato Lozano, Luan Reis Calixto, Daniel G. Cyr, Wilma De Grava Kempinas


  • Open Access

    Ethylene dimethanesulfonate effects on gene promoter activities related to the endocrine function of immortalized Leydig cell lines R2C and MA-10

    by Jorge W.F. de Barros, Kenley Joule Pierre, Wilma De G. Kempinas, Jacques J. Tremblay

  • Reproductive outcomes of neonatal exposure to betamethasone in male and female rats

    by Thamiris Moreira Figueiredo, Jorge Willian Franco de Barros, Cibele dos Santos Borges, Tainá Louise Pacheco, Josiane de Lima Rosa, Janete Aparecida Anselmo‐Franci, Wilma De Grava Kempinas

    Betamethasone (BM) is the drug of choice for antenatal corticosteroid therapy for women at risk of preterm delivery because it induces fetal lung maturation and enhances survival after birth. However, our group reported evidence of fetal programming and impaired reproductive development and function in rats exposed during the critical window of genital system development. Therefore, we aimed to investigate the effects of BM on the sexual development of rats in the period that corresponds to antenatal corticosteroid therapy in humans. Male and female rats were exposed subcutaneously to BM at 0.1 μg/g of pups' body weight or to a NaCl 0.9% solution (control) on postnatal days 1–3. It was observed that neonatal exposure to BM decreased body weight and weight gain in male and female rats during treatment. The estrous cycle was deregulated and LH level was decreased in female rats. In male rats, the sperm concentration in the caput–corpus of the epididymis was decreased, whereas the sperm transit time and sperm concentration in the cauda of the epididymis were increased. Our results demonstrated that neonatal exposure to BM impaired body growth of male and female rats, deregulated the estrous cycle of female rats, and altered sperm quality of male rats. Therefore, BM exposure from postnatal days 1 to 3 corroborated results previously observed after prenatal exposure to this drug. Despite the recognized importance of human antenatal corticosteroid therapy, the findings of this study should encourage further studies in order to minimize possible adverse postnatal effects.


  • Reproductive Development of Male Rats Exposed In Utero to Stress and/or Sertraline

    by Ana Flávia Quiarato Lozano, Bruna Marques Tavares, Patrícia Villela e Silva, Jorge Willian Franco de Barros, Wilma De Grava Kempinas

    Despite increased prescription of sertraline during pregnancy, little is known about its action on reproductive development. Therefore, this study aimed to investigate the impact that stress, associated or not with sertraline, causes on the reproductive development of male rats. Pregnant Wistar rats were divided into 4 groups (n = 16/group): CO—received filtered water; SE—received 20 mg/kg sertraline; ST—submitted to restraint stress and received filtered water; SS—submitted to restraint stress and received sertraline. The treatment was carried out from gestational days (GDs) 13–20. The animals were euthanized on GD 20 (n = 8/group), postnatal day (PND) 45 (n = 8/group), and PND 110 (n = 8/group). The testes and epididymis were analyzed histologically, and immunohistochemistry was performed on the testes by proliferating cell nuclear antigen (PCNA) and the Wilms tumor protein (Wt1). Sperm quality was also analyzed on PND 110. The evolution of body weight, anogenital distance (AGD), and puberty installation day were also verified. Statistical analysis: 2-way ANOVA or Kruskal-Wallis test (p ≤ .05). Fetal testes presented a large number of acidophilic cells in the sertraline-exposed groups. The SS group also showed a decrease in the nuclear volume of Leydig cells. This same group showed low expression of PCNA and Wt1, decreased weight of the testes and epididymis, lower AGD, and delayed puberty installation. The adulthood groups exposed to sertraline presented alterations in sperm morphology and motility. The results demonstrated that prenatal exposure to sertraline compromises the development of the rat reproductive system.


  • Rosuvastatin exposure in female Wistar rats alters uterine contractility and do not show evident (anti)estrogenic effects

    by Jorge Willian Franco de Barros, Patrícia Villela e Silva, Gustavo Venâncio da Silva, Katiussia Pinho da Silva, Cibele dos Santos Borges, André Mueller, Lethícia Valencise, André Sampaio Pupo, Wilma De Grava Kempinas

    Statins are 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitor drugs that lead to serum-cholesterol-lowering effects. Rosuvastatin, a third-generation statin, has shown better results in reducing cholesterol concentrations when compared to other widely prescribed statins. Recent studies by our group reported that rosuvastatin impairs reproductive function in rats possibly by disrupting the reproductive-endocrine axis. In this study, we evaluated whether rosuvastatin presents estrogenic or antiestrogenic effects, by an in vivo uterotrophic assay in rats, and investigated the direct effect of this drug upon rat uterine tissue contractility both in non-gravid and gravid periods. Rosuvastatin exposure in vivo at doses of 0 (control), 3, and 10 mg/kg/d was not associated with estrogenic or antiestrogenic effects on uterine tissue. However, in vivo (doses of 0, 3, and 10 mg/kg/d) and ex vivo (concentrations of 0, 1, 10, and 100 µg/mL) exposures to this drug were related to alterations in uterine basal contraction pattern. Furthermore, in vivo and ex vivo rosuvastatin exposures potentially modulate the action of uterine contraction inducers carbachol, norepinephrine, and prostaglandin E2. Thus, rosuvastatin can affect uterine physiology not necessarily by an endocrine mechanism related to the estrogen signaling, but possibly by its pleiotropic effects, with indirect tissue and cellular interactions, since in vivo and ex vivo exposures of uterine fragments to rosuvastatin presented different responses in uterine contractile parameters, which require further studies upon the precise mechanism of action of this drug in female reproductive function.


  • Open Access

    Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty

    by Jorge W.F. Barros, Karolina S. Tonon, Cibele S. Borges, Patrícia V. Silva, Ana F.Q. Lozano, Tainá L. Pacheco, Janete A. Anselmo-Franci, Wilma G. Kempinas


  • Prenatal exposure to betamethasone causes intergenerational impairment of epididymal development in the rat

    by W. G. Kempinas, C. S. Borges, G. A. A. Leite, T. M. Figueiredo, M. Gregory, D. G. Cyr

    Background: Studies on epididymal toxicology are scarce. Betamethasone (BM) is a glucocorticoid used in clinical practice for antenatal therapy. We previously reported changes to testicular morphology, altered sperm quality, and fertility in adult rats following intrauterine administration of BM.Objectives: Given that high levels of corticosteroids during gestation lead to fetal androgen depletion, and the essential role of testosterone during epididymal development, here we investigated epididymal morphology and physiology in the F1 and F2 male offspring of female rats treated with BM during gestation.Materials and methods: Pregnant rats were randomly divided into two experimental groups: control (saline vehicle, n = 11) and BM‐treated group (0.1 mg/kg betamethasone 21‐phosphate disodium, n = 13). Rats received an intramuscular injection of vehicle or BM on gestational days 12, 13, 18, and 19. This encompasses the beginning of the critical window of male rat reproductive tract development. A subset of three males from each litter (n = 5 litters/group) was used: One rat per litter was euthanized at puberty, one was euthanized at adulthood, while the others were mated with a non‐treated female to obtain the F2 generation. The same protocol described for the F1 was applied for F2, except for the mating protocol.Results: In both F1 and F2 generations, prenatal BM exposure resulted in delayed differentiation of the cauda epididymal epithelium, characterized by increased cribriform appearance on PND 45, and displayed weaker or non‐detectable Cx43 immunostaining. Furthermore, in the F1 generation only, immunostaining of TP63, a transcription factor expressed in basal cells, appeared more intense with a greater number of TP63‐positive cells observed in the cauda epididymis. In adults, the epithelial area was reduced in the F1 BM rats. The contractile activity of isolated epididymal ducts was comparable between groups.Discussion and Conclusion: Prenatal BM exposure leads to intergenerational impairment in the development and structure of the rat epididymis.